39 related articles for article (PubMed ID: 30829691)
1. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.
Butt AS; Hamid S; Wadalawala AA; Ghufran M; Javed AA; Farooq O; Ahmed B; Ul Haq T; Jafri W
BMC Res Notes; 2013 Apr; 6():137. PubMed ID: 23566475
[TBL] [Abstract][Full Text] [Related]
3. Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
Forouzannia F; Hamadeh A; Passos-Castilho AM; Erman A; Yu A; Feng Z; Janjua NZ; Sander B; Greenaway C; Wong WWL
Liver Int; 2024 Jun; 44(6):1383-1395. PubMed ID: 38445848
[TBL] [Abstract][Full Text] [Related]
4. Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.
Akiyama T; Mizuta T; Kawazoe S; Eguchi Y; Kawaguchi Y; Takahashi H; Ozaki I; Fujimoto K
World J Gastroenterol; 2011 Feb; 17(7):914-21. PubMed ID: 21412500
[TBL] [Abstract][Full Text] [Related]
5. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women.
Amr S; Iarocci EA; Nasr GR; Saleh D; Blancato J; Shetty K; Loffredo CA
BMC Cancer; 2014 Nov; 14():893. PubMed ID: 25432765
[TBL] [Abstract][Full Text] [Related]
6. How do persistent infections with hepatitis C virus cause liver cancer?
Mitchell JK; Lemon SM; McGivern DR
Curr Opin Virol; 2015 Oct; 14():101-8. PubMed ID: 26426687
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review.
Farooq HZ; James M; Abbott J; Oyibo P; Divall P; Choudhry N; Foster GR
World J Gastrointest Oncol; 2024 Apr; 16(4):1596-1612. PubMed ID: 38660636
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: A global view.
Yang JD; Roberts LR
Nat Rev Gastroenterol Hepatol; 2010 Aug; 7(8):448-58. PubMed ID: 20628345
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C in Canada and the importance of risk-based screening.
Ha S; Totten S; Pogany L; Wu J; Gale-Rowe M
Can Commun Dis Rep; 2016 Mar; 42(3):57-62. PubMed ID: 29770005
[TBL] [Abstract][Full Text] [Related]
10. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross-sectional retrospective study.
Awadh A; Badri Z; Alansari N; Alkhiri A; Baharoon H; Niaz A; Al-Kathiri A; Ghulam E; Khan M
Health Sci Rep; 2024 May; 7(5):e2055. PubMed ID: 38690003
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens.
Tayyab GUN; Rasool S; Nasir B; Rubi G; Abou-Samra AB; Butt AA
BMC Gastroenterol; 2020 Apr; 20(1):93. PubMed ID: 32252635
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.
Idrees M; Rafique S; Rehman I; Akbar H; Yousaf MZ; Butt S; Awan Z; Manzoor S; Akram M; Aftab M; Khubaib B; Riazuddin S
World J Gastroenterol; 2009 Oct; 15(40):5080-5. PubMed ID: 19860002
[TBL] [Abstract][Full Text] [Related]
13. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
14. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma.
Colombo M
J Hepatol; 1999; 31 Suppl 1():25-30. PubMed ID: 10622556
[TBL] [Abstract][Full Text] [Related]
15. [Current status and clinical course of hepatitis C virus in Korea].
Kwon JH; Bae SH
Korean J Gastroenterol; 2008 Jun; 51(6):360-7. PubMed ID: 18604137
[TBL] [Abstract][Full Text] [Related]
16. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients.
Ul Abideen Z; Siddique S; Nasrullah I; Khan JS; Rehman S; Tong Y; Qamar R; Butt AM
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1103-1109. PubMed ID: 30829691
[TBL] [Abstract][Full Text] [Related]
17. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
Reddy A; May E; Ehrinpreis M; Mutchnick M
World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
